Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Depression treatment and its impact upon the quality of life in patients with diabetes type 2 - the Croatian study.

Filipcić I, Margetić B, Simunović I, Jakovljević M.

Psychiatr Danub. 2010 Jun;22(2):231-5.

2.

Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.

Russell JM, Kornstein SG, Shea MT, McCullough JP, Harrison WM, Hirschfeld RM, Keller MB.

J Clin Psychiatry. 2003 May;64(5):554-61.

PMID:
12755659
3.

A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.

Lydiard RB, Stahl SM, Hertzman M, Harrison WM.

J Clin Psychiatry. 1997 Nov;58(11):484-91.

PMID:
9413414
4.

Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.

Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ.

J Clin Psychiatry. 1998 Dec;59(12):669-75.

PMID:
9921701
5.

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.

Brady KT, Clary CM.

Compr Psychiatry. 2003 Sep-Oct;44(5):360-9.

PMID:
14505296
6.

The effect of depression on quality of life of patients with type II diabetes mellitus.

Eren I, Erdi O, Sahin M.

Depress Anxiety. 2008;25(2):98-106.

PMID:
17311266
7.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
8.

The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.

Katon WJ, Von Korff M, Lin EH, Simon G, Ludman E, Russo J, Ciechanowski P, Walker E, Bush T.

Arch Gen Psychiatry. 2004 Oct;61(10):1042-9.

PMID:
15466678
9.

Depression, quality of life, and glycemic control in individuals with type 2 diabetes.

Lee HJ, Chapa D, Kao CW, Jones D, Kapustin J, Smith J, Krichten C, Donner T, Thomas SA, Friedmann E.

J Am Acad Nurse Pract. 2009 Apr;21(4):214-24. doi: 10.1111/j.1745-7599.2009.00396.x.

PMID:
19366380
10.

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.

Psychosom Med. 1997 May-Jun;59(3):241-50.

PMID:
9178335
11.

Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.

Kocsis JH, Schatzberg A, Rush AJ, Klein DN, Howland R, Gniwesch L, Davis SM, Harrison W.

Arch Gen Psychiatry. 2002 Aug;59(8):723-8.

PMID:
12150648
13.

Impact of pain on depression treatment response in primary care.

Bair MJ, Robinson RL, Eckert GJ, Stang PE, Croghan TW, Kroenke K.

Psychosom Med. 2004 Jan-Feb;66(1):17-22.

PMID:
14747633
14.

[Antidepressants consumption in the global population in France].

Olié JP, Elomari F, Spadone C, Lépine JP.

Encephale. 2002 Sep-Oct;28(5 Pt 1):411-7. French.

PMID:
12386542
15.

Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome.

Swenson JR, O'Connor CM, Barton D, Van Zyl LT, Swedberg K, Forman LM, Gaffney M, Glassman AH; Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group.

Am J Cardiol. 2003 Dec 1;92(11):1271-6.

PMID:
14636902
16.

Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy.

Aberg-Wistedt A, Agren H, Ekselius L, Bengtsson F, Akerblad AC.

J Clin Psychopharmacol. 2000 Dec;20(6):645-52.

PMID:
11106136
17.

The course of major depression in diabetes.

Lustman PJ, Griffith LS, Freedland KE, Clouse RE.

Gen Hosp Psychiatry. 1997 Mar;19(2):138-43.

PMID:
9097068
18.

Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.

Karaiskos D, Tzavellas E, Ilias I, Liappas I, Paparrigopoulos T.

Int J Clin Pract. 2013 Mar;67(3):257-60. doi: 10.1111/ijcp.12112.

PMID:
23409693
19.

Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness.

Sheikh JI, Cassidy EL, Doraiswamy PM, Salomon RM, Hornig M, Holland PJ, Mandel FS, Clary CM, Burt T.

J Am Geriatr Soc. 2004 Jan;52(1):86-92. Erratum in: J Am Geriatr Soc. 2004 Jul;52(7):1228.

PMID:
14687320
20.

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB, Williams MM, Gelenberg AJ, Ciechanowski PS, Hirsch IB.

Arch Gen Psychiatry. 2006 May;63(5):521-9.

PMID:
16651509

Supplemental Content

Support Center